3 cheap stocks that could turn $1,000 into $10,000
The post 3 cheap stocks that could turn $1,000 into $10,000 appeared on BitcoinEthereumNews.com.
At the start of 2025, the stock market appeared unstable as most major assets were, seemingly, very overvalued. Despite this, there was no shortage of opportunities for savvy investors to find undervalued, cheap stocks that enabled them to turn a $1,000 into $10,000 of profit. The start of 2026 appears similar, and though some fear – as they have for a long time – that the artificial intelligence (AI) boom is a bubble about to burst, the S&P 500 stock market index has, on multiple days in January, closed at unprecedented highs. With both the dangers and opportunities in mind, Finbold decided to examine potentially undervalued stocks that could help investors turn relatively modest investments into hefty returns in the mid to long-term. Rocket Pharmaceuticals (NASDAQ: RCKT) Rocket Pharmaceuticals (NASDAQ: RCKT) represents one of the binaries frequently found among cheap stocks of very ambitious companies. In a nutshell, the firm is a clinical-stage gene therapy developer examining rare diseases. RCKT shares are also, by any standard, very cheap in January 2026 due to a trial-related calamity in early 2025 that sent them plunging from approximately $6.59 to about $2.50 and, eventually, to their press time price of $3.80. RCKT stock YTD price chart. Source: Google Rocket’s latest stock market trend has, however, been mildly positive with an 8% year-to-date (YTD) rally, and the company has continued working on novel treatments such as adeno-associated viral (AAV) and lentiviral (LV) gene therapy programs, with the project targeting the Danon disease being especially noteworthy, considering it is in Phase 2 trials. Simultaneously, while there is no doubt that a Rocket Pharmaceuticals investment is only for the risk-seekers, the potential payouts should the company succeed are staggering. In fact, the potential upside is so significant that the average Wall Street 12-month price target for…
Filed under: News - @ January 14, 2026 2:28 pm